Kinesin inhibitor, Litronesib racemate, Purity ≥98%

Cat. No.: X24-08-YM333

Kinesin inhibitor, Litronesib racemate, Purity ≥98%

Synonym: 546111-97-1; LY-2523355 Racemate; LY2523355; LY 2523355; KF-89617 Racemate; KF89617; KF 89617; N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide

  • CAS Number: 546111-97-1
  • Compound CID: 11272219
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Litronesib racemate is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting kinesin.
Molecular Weight
511.7
Molecular Formula
C23H37N5O4S2
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Litronesib racemate is a cytoskeletal signaling inhibitor that can be used for its potential to interfere with mitotic spindle function, which can lead to cell cycle arrest and apoptosis in cancer cells, thus holding promise as a cancer therapeutic.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.